Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Química
Print version ISSN 0120-2804On-line version ISSN 2357-3791
Abstract
RAMIREZ PANTI, Rocio I. et al. Pyrazinamide-isoniazid hybrid: synthesis optimisation, characterisation, and antituberculous activity. Rev.Colomb.Quim. [online]. 2021, vol.50, n.3, pp.16-23. Epub July 20, 2022. ISSN 0120-2804. https://doi.org/10.15446/rev.colomb.quim.v50n3.96424.
Over time, the effective resistance mechanisms to various first- and second-line drugs against the disease of tuberculosis make its treatment extremely difficult. This work presents a new approach to synthesizing a hybrid of antituberculosis medications: isoniazid (INH) and pyrazinamide (PZA). The synthesis was performed using ultrasound-assisted synthesis to obtain an overall yield of 70%, minimizing the reaction time from 7 to 1 h. The evaluation of the biological activity of the hybrid (compound 2) was tested using the tetrazolium microplate assay (TEMA), showing inhibition in the growth of Mycobacterium tuberculosis H37Rv at a concentration of 0.025 mM at pH 6.0 and 6.7.
Keywords : tuberculosis TEMA; MIC; ultrasound; isoniazid; pyrazinamide.